Bicycle Therapeutics
BCYC · NASDAQ
$3.60+$0.065 (+1.84%)TodayMarket closed ·
Prev close $3.54
Who owns BCYC
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 40.9% of BCYC’s shares.
- Baker Bros. Advisors LP15.6%
- Forbion Capital Partners5.0%
- Armistice Capital LLC4.9%
- Long Focus Capital Management LLC4.7%
- Next 6 largest institutions10.8%
- All other shareholders59.1%
| Holder | Shares | % of shares |
|---|---|---|
| Baker Bros. Advisors LP | 10.89M | 15.59% |
| Forbion Capital Partners | 3.47M | 4.97% |
| Armistice Capital LLC | 3.40M | 4.87% |
| Long Focus Capital Management LLC | 3.31M | 4.74% |
| Acadian Asset Management LLC | 1.97M | 2.82% |
| Renaissance Technologies LLC | 1.53M | 2.20% |
| GSK plc | 1.53M | 2.19% |
| T. Rowe Price Associates, Inc. | 902.15K | 1.29% |
| Marshall Wace LLP | 797.94K | 1.14% |
| Qube Research & Technologies Ltd | 775.57K | 1.11% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| T. Rowe Price Health Sciences Fund | 628.42K | 0.90% |
| iShares Biotechnology ETF | 276.69K | 0.40% |
| Old Westbury Small & Mid Cap Strategies Fund | 265.97K | 0.38% |
| Goldman Sachs Multi-Manager US Sm Cp Eqty | 99.18K | 0.14% |
| Virtus Biotech Clinical Trials ETF | 77.44K | 0.11% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $124.50K (25 trades) of BCYC on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Perry Jennifer Scott | Sale | 326 | $1.23K |
| Perry Jennifer Scott | Sale | 30 | $107 |
| Perry Jennifer Scott | Sale | 326 | $1.23K |
| Perry Jennifer Scott | Sale | 80 | $285 |
| Hannay Michael Charles Ferguson | Sale | 242 | $864 |
| Thompson Travis Alvin | Sale | 79 | $282 |
| Lee Kevin | Sale | 1.64K | $5.85K |
| Skynner Michael | Sale | 503 | $1.80K |
| Perry Jennifer Scott | Sale | 1.09K | $3.80K |
| Swanton Robert Charles | Sale | 3.43K | $11.91K |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.30M
- Days to cover
- 8.72
- % of shares outstanding
- 4.73%
- Average daily volume
- 378.57K
- Change since last report
- −0.9%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.